← Back to Episodes
PODCAST

Acupuncture vs. SSRIs, Your Liver, and the BRCA Question

July 30, 2026·10:54·Episode 91

Quick Summary

This episode covers three new studies from the research pipeline: a retrospective cohort comparing TCM-acupuncture with SSRIs for perimenopausal depression, a qualitative study on postmenopausal women managing a liver condition that barely registers in menopause conversations, and an analysis of how BRCA genetic test results affect psychological wellbeing. Nykki reads the methods so you don't have to.

Acupuncture vs. SSRIs, Your Liver, and the BRCA Question

0:000:00

Key Takeaways

  • The acupuncture-vs-SSRIs study is retrospective and cohort-based — not a randomized controlled trial — which limits how far its conclusions can travel, regardless of which treatment looked better.
  • Metabolic dysfunction-associated steatotic liver disease (MASLD) is more common after menopause due to estrogen loss, and a new qualitative study finds postmenopausal women feel largely unsupported in managing it.
  • The BRCA study found that both positive and negative test results produce measurable psychological effects — a negative result does not simply return people to their baseline emotional state.
  • Perimenopausal depression has biological underpinnings — specifically shifts in estradiol, serotonin, and BDNF — that distinguish it from general depression, and treatment research in this population is still thin.
  • Qualitative research in menopause medicine is undervalued; it captures what surveys miss about how women actually experience and navigate chronic conditions.

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.